Review





Similar Products

94
ATCC mouse hybridoma c1q m1
Mouse Hybridoma C1q M1, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/Mouse+hybridoma+C1q-M1+7788-1(M)+051613/us12534522-1279-13-21
Average 94 stars, based on 1 article reviews
mouse hybridoma c1q m1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Hycult Biotech c1q mab
<t>C1q</t> exacerbates hepatic steatosis, fibrosis and inflammatory processes. A-B. E. faecalis and loss of IGSF9 led to liver C1q accumulation. C1q content in mice liver ( n = 6) and in 3D liver spheroid supernatant ( n = 3) from previous experiments were detected using IHC (A) and ELISA (B). Statistical analyzes: Two-way ANOVA and Šídák's multiple comparison test; unpaired two-tailed Student's t-test. C-F. C1q enhanced steatosis and fibrosis in vitro. Oil red o staining of HepG2 cells after stimulated with oleic acid (OA, 20 μg/mL) with/without C1q (1 μg/mL) for 24 h, n = 3 (C, D). Expression of α -SMA protein level (E) and fibrosis marker genes ( COL1A1 , ACTA2 , TIMP1 ) (F) and in LX2 cells after stimulated with TGF-β1 (5 ng/mL) with/without C1q (1 μg/mL) for 24 h, n = 3. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test; two-way ANOVA and Šídák's multiple comparison test. G. C1q was negatively correlated with IGSF9 and was positively correlated with FABP4 and α -SMA in HCC samples. Representative IGSF9, C1q, FABP4 and α -SMA staining and correlation analysis in 22 MAFLD-HCC specimens. *: p < 0.05, **: p < 0.01, ***: p < 0.001.
C1q Mab, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/C1q%2C+Mouse%2C+mAb+JL-1/pmc12938874-103-21-23
Average 93 stars, based on 1 article reviews
c1q mab - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Cedarlane anti mouse c1q pe antibody
<t>C1q</t> exacerbates hepatic steatosis, fibrosis and inflammatory processes. A-B. E. faecalis and loss of IGSF9 led to liver C1q accumulation. C1q content in mice liver ( n = 6) and in 3D liver spheroid supernatant ( n = 3) from previous experiments were detected using IHC (A) and ELISA (B). Statistical analyzes: Two-way ANOVA and Šídák's multiple comparison test; unpaired two-tailed Student's t-test. C-F. C1q enhanced steatosis and fibrosis in vitro. Oil red o staining of HepG2 cells after stimulated with oleic acid (OA, 20 μg/mL) with/without C1q (1 μg/mL) for 24 h, n = 3 (C, D). Expression of α -SMA protein level (E) and fibrosis marker genes ( COL1A1 , ACTA2 , TIMP1 ) (F) and in LX2 cells after stimulated with TGF-β1 (5 ng/mL) with/without C1q (1 μg/mL) for 24 h, n = 3. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test; two-way ANOVA and Šídák's multiple comparison test. G. C1q was negatively correlated with IGSF9 and was positively correlated with FABP4 and α -SMA in HCC samples. Representative IGSF9, C1q, FABP4 and α -SMA staining and correlation analysis in 22 MAFLD-HCC specimens. *: p < 0.05, **: p < 0.01, ***: p < 0.001.
Anti Mouse C1q Pe Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/Anti-Mouse+Complement+Component+C1q%2C+PE+(Clone+RmC7H8)+(rat+IgG1)/pm42887494-308-45-48
Average 92 stars, based on 1 article reviews
anti mouse c1q pe antibody - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology rat anti mouse c1q 7h8 conjugated to fitc
( A-B ) Mouse serum was assayed using a multiplex Luminex platform and antibodies quantified by mean fluorescence intensity (MFI); only <t>anti-C1q</t> antibodies are shown here, see for other antigens. 6-8 week old ( A ) C57BL/6 mice and ( B ) NZBxW/F1 mice were injected intraperitoneally with curli purified from Salmonella Typhimurium (STm) biofilms, or sterile PBS for controls, weekly for ( A ) 12 weeks or ( B ) 5 weeks. ( C-F ) Anti-C1q antibodies in serum (diluted 1:50) were detected using ELISA, normalized to aliquots of serum from an untreated aged MRL/lpr mouse as a positive control (1:50, top dotted line) and a negative control without serum (bottom dotted line). ( C ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from STm biofilms, 100 µg/kg LPS, 50 µg curli and 50 µg/kg LPS, or PBS for untreated controls, weekly for 3 weeks . ( D ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from the biofilm of an E. coli isolate from the human microbiome (hEC), an E. coli isolate from the mouse microbiome (mEC), STm biofilms, or PBS for untreated controls, weekly for 4 weeks . ( E ) 129Sv mice were infected intragastrically with 10 7 CFU of wild-type (WT) STm strain IR715, the isogenic curli-deficient mutant csgBA , or LB broth for uninfected controls, in two replicate experiments, and Week 6 serum was assayed. ( F ) C57BL/6 mice were infected intragastrically with 10 7 CFU of STm spiB or invAspiB mutant, or LB broth for uninfected controls, and monitored for 10 weeks. Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: ( A-B ) Unpaired t-test, ( C-E ) One-way ANOVA, or ( E ) Mixed-effects analysis, with Tukey’s multiple comparisons, comparisons within the legend indicating overall column factor (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Rat Anti Mouse C1q 7h8 Conjugated To Fitc, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/C1q-A+Antibody/pmc13652334-248-32-39
Average 93 stars, based on 1 article reviews
rat anti mouse c1q 7h8 conjugated to fitc - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Hycult Biotech mouse anti c1q
( A-B ) Mouse serum was assayed using a multiplex Luminex platform and antibodies quantified by mean fluorescence intensity (MFI); only <t>anti-C1q</t> antibodies are shown here, see for other antigens. 6-8 week old ( A ) C57BL/6 mice and ( B ) NZBxW/F1 mice were injected intraperitoneally with curli purified from Salmonella Typhimurium (STm) biofilms, or sterile PBS for controls, weekly for ( A ) 12 weeks or ( B ) 5 weeks. ( C-F ) Anti-C1q antibodies in serum (diluted 1:50) were detected using ELISA, normalized to aliquots of serum from an untreated aged MRL/lpr mouse as a positive control (1:50, top dotted line) and a negative control without serum (bottom dotted line). ( C ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from STm biofilms, 100 µg/kg LPS, 50 µg curli and 50 µg/kg LPS, or PBS for untreated controls, weekly for 3 weeks . ( D ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from the biofilm of an E. coli isolate from the human microbiome (hEC), an E. coli isolate from the mouse microbiome (mEC), STm biofilms, or PBS for untreated controls, weekly for 4 weeks . ( E ) 129Sv mice were infected intragastrically with 10 7 CFU of wild-type (WT) STm strain IR715, the isogenic curli-deficient mutant csgBA , or LB broth for uninfected controls, in two replicate experiments, and Week 6 serum was assayed. ( F ) C57BL/6 mice were infected intragastrically with 10 7 CFU of STm spiB or invAspiB mutant, or LB broth for uninfected controls, and monitored for 10 weeks. Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: ( A-B ) Unpaired t-test, ( C-E ) One-way ANOVA, or ( E ) Mixed-effects analysis, with Tukey’s multiple comparisons, comparisons within the legend indicating overall column factor (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Mouse Anti C1q, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/C1q%2C+Mouse%2C+mAb+JL-1%2C+biotinylated/bio_rxiv__64898__2026__06__29__735292-348-88-89
Average 94 stars, based on 1 article reviews
mouse anti c1q - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Hycult Biotech biotinylated anti mouse c1q antibody
( A-B ) Mouse serum was assayed using a multiplex Luminex platform and antibodies quantified by mean fluorescence intensity (MFI); only <t>anti-C1q</t> antibodies are shown here, see for other antigens. 6-8 week old ( A ) C57BL/6 mice and ( B ) NZBxW/F1 mice were injected intraperitoneally with curli purified from Salmonella Typhimurium (STm) biofilms, or sterile PBS for controls, weekly for ( A ) 12 weeks or ( B ) 5 weeks. ( C-F ) Anti-C1q antibodies in serum (diluted 1:50) were detected using ELISA, normalized to aliquots of serum from an untreated aged MRL/lpr mouse as a positive control (1:50, top dotted line) and a negative control without serum (bottom dotted line). ( C ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from STm biofilms, 100 µg/kg LPS, 50 µg curli and 50 µg/kg LPS, or PBS for untreated controls, weekly for 3 weeks . ( D ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from the biofilm of an E. coli isolate from the human microbiome (hEC), an E. coli isolate from the mouse microbiome (mEC), STm biofilms, or PBS for untreated controls, weekly for 4 weeks . ( E ) 129Sv mice were infected intragastrically with 10 7 CFU of wild-type (WT) STm strain IR715, the isogenic curli-deficient mutant csgBA , or LB broth for uninfected controls, in two replicate experiments, and Week 6 serum was assayed. ( F ) C57BL/6 mice were infected intragastrically with 10 7 CFU of STm spiB or invAspiB mutant, or LB broth for uninfected controls, and monitored for 10 weeks. Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: ( A-B ) Unpaired t-test, ( C-E ) One-way ANOVA, or ( E ) Mixed-effects analysis, with Tukey’s multiple comparisons, comparisons within the legend indicating overall column factor (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Biotinylated Anti Mouse C1q Antibody, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/C1q%2C+Mouse%2C+mAb+JL-1%2C+biotinylated/us12662526-1596-91-95
Average 94 stars, based on 1 article reviews
biotinylated anti mouse c1q antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Proteintech mouse anti c1q primary ab
( A-B ) Mouse serum was assayed using a multiplex Luminex platform and antibodies quantified by mean fluorescence intensity (MFI); only <t>anti-C1q</t> antibodies are shown here, see for other antigens. 6-8 week old ( A ) C57BL/6 mice and ( B ) NZBxW/F1 mice were injected intraperitoneally with curli purified from Salmonella Typhimurium (STm) biofilms, or sterile PBS for controls, weekly for ( A ) 12 weeks or ( B ) 5 weeks. ( C-F ) Anti-C1q antibodies in serum (diluted 1:50) were detected using ELISA, normalized to aliquots of serum from an untreated aged MRL/lpr mouse as a positive control (1:50, top dotted line) and a negative control without serum (bottom dotted line). ( C ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from STm biofilms, 100 µg/kg LPS, 50 µg curli and 50 µg/kg LPS, or PBS for untreated controls, weekly for 3 weeks . ( D ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from the biofilm of an E. coli isolate from the human microbiome (hEC), an E. coli isolate from the mouse microbiome (mEC), STm biofilms, or PBS for untreated controls, weekly for 4 weeks . ( E ) 129Sv mice were infected intragastrically with 10 7 CFU of wild-type (WT) STm strain IR715, the isogenic curli-deficient mutant csgBA , or LB broth for uninfected controls, in two replicate experiments, and Week 6 serum was assayed. ( F ) C57BL/6 mice were infected intragastrically with 10 7 CFU of STm spiB or invAspiB mutant, or LB broth for uninfected controls, and monitored for 10 weeks. Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: ( A-B ) Unpaired t-test, ( C-E ) One-way ANOVA, or ( E ) Mixed-effects analysis, with Tukey’s multiple comparisons, comparisons within the legend indicating overall column factor (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Mouse Anti C1q Primary Ab, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/C1qA+Antibody/pm41382128-145-44-50
Average 93 stars, based on 1 article reviews
mouse anti c1q primary ab - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cedarlane anti c1q antibody
( A-B ) Mouse serum was assayed using a multiplex Luminex platform and antibodies quantified by mean fluorescence intensity (MFI); only <t>anti-C1q</t> antibodies are shown here, see for other antigens. 6-8 week old ( A ) C57BL/6 mice and ( B ) NZBxW/F1 mice were injected intraperitoneally with curli purified from Salmonella Typhimurium (STm) biofilms, or sterile PBS for controls, weekly for ( A ) 12 weeks or ( B ) 5 weeks. ( C-F ) Anti-C1q antibodies in serum (diluted 1:50) were detected using ELISA, normalized to aliquots of serum from an untreated aged MRL/lpr mouse as a positive control (1:50, top dotted line) and a negative control without serum (bottom dotted line). ( C ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from STm biofilms, 100 µg/kg LPS, 50 µg curli and 50 µg/kg LPS, or PBS for untreated controls, weekly for 3 weeks . ( D ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from the biofilm of an E. coli isolate from the human microbiome (hEC), an E. coli isolate from the mouse microbiome (mEC), STm biofilms, or PBS for untreated controls, weekly for 4 weeks . ( E ) 129Sv mice were infected intragastrically with 10 7 CFU of wild-type (WT) STm strain IR715, the isogenic curli-deficient mutant csgBA , or LB broth for uninfected controls, in two replicate experiments, and Week 6 serum was assayed. ( F ) C57BL/6 mice were infected intragastrically with 10 7 CFU of STm spiB or invAspiB mutant, or LB broth for uninfected controls, and monitored for 10 weeks. Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: ( A-B ) Unpaired t-test, ( C-E ) One-way ANOVA, or ( E ) Mixed-effects analysis, with Tukey’s multiple comparisons, comparisons within the legend indicating overall column factor (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Anti C1q Antibody, supplied by Cedarlane, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-c1q/Anti-Human+Complement+Component+C1q%2C+PE+(Clone+MhC5B9)+(mouse+IgG1)/us12331134-1507-24-26
Average 93 stars, based on 1 article reviews
anti c1q antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

Image Search Results


C1q exacerbates hepatic steatosis, fibrosis and inflammatory processes. A-B. E. faecalis and loss of IGSF9 led to liver C1q accumulation. C1q content in mice liver ( n = 6) and in 3D liver spheroid supernatant ( n = 3) from previous experiments were detected using IHC (A) and ELISA (B). Statistical analyzes: Two-way ANOVA and Šídák's multiple comparison test; unpaired two-tailed Student's t-test. C-F. C1q enhanced steatosis and fibrosis in vitro. Oil red o staining of HepG2 cells after stimulated with oleic acid (OA, 20 μg/mL) with/without C1q (1 μg/mL) for 24 h, n = 3 (C, D). Expression of α -SMA protein level (E) and fibrosis marker genes ( COL1A1 , ACTA2 , TIMP1 ) (F) and in LX2 cells after stimulated with TGF-β1 (5 ng/mL) with/without C1q (1 μg/mL) for 24 h, n = 3. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test; two-way ANOVA and Šídák's multiple comparison test. G. C1q was negatively correlated with IGSF9 and was positively correlated with FABP4 and α -SMA in HCC samples. Representative IGSF9, C1q, FABP4 and α -SMA staining and correlation analysis in 22 MAFLD-HCC specimens. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Journal: Gut Microbes Reports

Article Title: Enterococcus faecalis impairs IGSF9-dependent C1q degradation to accelerate MAFLD-HCC progression

doi: 10.1080/29933935.2025.2600896

Figure Lengend Snippet: C1q exacerbates hepatic steatosis, fibrosis and inflammatory processes. A-B. E. faecalis and loss of IGSF9 led to liver C1q accumulation. C1q content in mice liver ( n = 6) and in 3D liver spheroid supernatant ( n = 3) from previous experiments were detected using IHC (A) and ELISA (B). Statistical analyzes: Two-way ANOVA and Šídák's multiple comparison test; unpaired two-tailed Student's t-test. C-F. C1q enhanced steatosis and fibrosis in vitro. Oil red o staining of HepG2 cells after stimulated with oleic acid (OA, 20 μg/mL) with/without C1q (1 μg/mL) for 24 h, n = 3 (C, D). Expression of α -SMA protein level (E) and fibrosis marker genes ( COL1A1 , ACTA2 , TIMP1 ) (F) and in LX2 cells after stimulated with TGF-β1 (5 ng/mL) with/without C1q (1 μg/mL) for 24 h, n = 3. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test; two-way ANOVA and Šídák's multiple comparison test. G. C1q was negatively correlated with IGSF9 and was positively correlated with FABP4 and α -SMA in HCC samples. Representative IGSF9, C1q, FABP4 and α -SMA staining and correlation analysis in 22 MAFLD-HCC specimens. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Article Snippet: For MAFLD C1q monoclonal antibody (mAb) intervention mouse model, male MAFLD mice aged six weeks were intraperitoneally injected with 10 μg C1q mAb (Hycult, HM1096) twice a week while others used mouse IgG2b isotype (BioXCell, BE0086) as control.

Techniques: Enzyme-linked Immunosorbent Assay, Comparison, Two Tailed Test, In Vitro, Staining, Expressing, Marker

Targeting Enterococcus faecalis /IGSF9/C1q axis has promising therapeutic effect on MAFLD. A. Bifidobacterium pseudolongum ( B. pseudolongum ) rescued IGSF9 downregulation caused by E. faecalis in vitro. Western blot analysis of IGSF9 protein in MAFLD 3D liver spheroids and primary hepatocytes stimulated with culture medium from bacteria lacking in DEN + HFD group on the basis of E. faecalis . Experiments were repeated three times. B, C. B. pseudolongum intervention alleviates MAFLD. MAFLD B. pseudolongum intervention model (B) was constructed based on the MAFLD model as previously described. 1 × 10 8 CFUs of B. pseudolongum or PBS (Ctrl) were fed to mice by daily gavage. Mice were sacrificed 28 weeks after intervention. Representative Oil red o, F4/80 and Masson staining in mice livers and quantification (C) showed alleviation after B. pseudolongum intervention, n = 6. Scale bar: 200 or 50 μm. Statistical analyzes: Unpaired two-tailed Student's t-test. D, E. Overexpressing IGSF9 alleviated steatosis in vitro. Oil red o staining (D) and quantification (E) of HepG2 cells overexpressing IGSF9 or not after stimulated with OA for 24 h, n = 3. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test. F, G. C1q neutralizing antibody alleviated hepatic steatosis, fibrosis and inflammatory processes in vivo. MAFLD C1q neutralizing antibody intervention model was constructed based on the MAFLD model subsequently injected with 10 μg C1q antibody two times a week (anti-C1q) or mouse IgG2b isotype (Ctrl) (F). Representative Oil red o, F4/80 and Masson staining in the livers and quantification, n = 6 (G). Scale bar: 200 or 50 μm. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Journal: Gut Microbes Reports

Article Title: Enterococcus faecalis impairs IGSF9-dependent C1q degradation to accelerate MAFLD-HCC progression

doi: 10.1080/29933935.2025.2600896

Figure Lengend Snippet: Targeting Enterococcus faecalis /IGSF9/C1q axis has promising therapeutic effect on MAFLD. A. Bifidobacterium pseudolongum ( B. pseudolongum ) rescued IGSF9 downregulation caused by E. faecalis in vitro. Western blot analysis of IGSF9 protein in MAFLD 3D liver spheroids and primary hepatocytes stimulated with culture medium from bacteria lacking in DEN + HFD group on the basis of E. faecalis . Experiments were repeated three times. B, C. B. pseudolongum intervention alleviates MAFLD. MAFLD B. pseudolongum intervention model (B) was constructed based on the MAFLD model as previously described. 1 × 10 8 CFUs of B. pseudolongum or PBS (Ctrl) were fed to mice by daily gavage. Mice were sacrificed 28 weeks after intervention. Representative Oil red o, F4/80 and Masson staining in mice livers and quantification (C) showed alleviation after B. pseudolongum intervention, n = 6. Scale bar: 200 or 50 μm. Statistical analyzes: Unpaired two-tailed Student's t-test. D, E. Overexpressing IGSF9 alleviated steatosis in vitro. Oil red o staining (D) and quantification (E) of HepG2 cells overexpressing IGSF9 or not after stimulated with OA for 24 h, n = 3. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test. F, G. C1q neutralizing antibody alleviated hepatic steatosis, fibrosis and inflammatory processes in vivo. MAFLD C1q neutralizing antibody intervention model was constructed based on the MAFLD model subsequently injected with 10 μg C1q antibody two times a week (anti-C1q) or mouse IgG2b isotype (Ctrl) (F). Representative Oil red o, F4/80 and Masson staining in the livers and quantification, n = 6 (G). Scale bar: 200 or 50 μm. Statistical analyzes: One-way ANOVA and Dunnett's multiple comparison test. *: p < 0.05, **: p < 0.01, ***: p < 0.001.

Article Snippet: For MAFLD C1q monoclonal antibody (mAb) intervention mouse model, male MAFLD mice aged six weeks were intraperitoneally injected with 10 μg C1q mAb (Hycult, HM1096) twice a week while others used mouse IgG2b isotype (BioXCell, BE0086) as control.

Techniques: In Vitro, Western Blot, Bacteria, Construct, Staining, Two Tailed Test, Comparison, In Vivo, Injection

( A-B ) Mouse serum was assayed using a multiplex Luminex platform and antibodies quantified by mean fluorescence intensity (MFI); only anti-C1q antibodies are shown here, see for other antigens. 6-8 week old ( A ) C57BL/6 mice and ( B ) NZBxW/F1 mice were injected intraperitoneally with curli purified from Salmonella Typhimurium (STm) biofilms, or sterile PBS for controls, weekly for ( A ) 12 weeks or ( B ) 5 weeks. ( C-F ) Anti-C1q antibodies in serum (diluted 1:50) were detected using ELISA, normalized to aliquots of serum from an untreated aged MRL/lpr mouse as a positive control (1:50, top dotted line) and a negative control without serum (bottom dotted line). ( C ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from STm biofilms, 100 µg/kg LPS, 50 µg curli and 50 µg/kg LPS, or PBS for untreated controls, weekly for 3 weeks . ( D ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from the biofilm of an E. coli isolate from the human microbiome (hEC), an E. coli isolate from the mouse microbiome (mEC), STm biofilms, or PBS for untreated controls, weekly for 4 weeks . ( E ) 129Sv mice were infected intragastrically with 10 7 CFU of wild-type (WT) STm strain IR715, the isogenic curli-deficient mutant csgBA , or LB broth for uninfected controls, in two replicate experiments, and Week 6 serum was assayed. ( F ) C57BL/6 mice were infected intragastrically with 10 7 CFU of STm spiB or invAspiB mutant, or LB broth for uninfected controls, and monitored for 10 weeks. Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: ( A-B ) Unpaired t-test, ( C-E ) One-way ANOVA, or ( E ) Mixed-effects analysis, with Tukey’s multiple comparisons, comparisons within the legend indicating overall column factor (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).

Journal: PLOS Pathogens

Article Title: Salmonella infection and biofilms drive anti-C1q and anti-dsDNA autoantibodies in systemic autoimmunity

doi: 10.1371/journal.ppat.1014666

Figure Lengend Snippet: ( A-B ) Mouse serum was assayed using a multiplex Luminex platform and antibodies quantified by mean fluorescence intensity (MFI); only anti-C1q antibodies are shown here, see for other antigens. 6-8 week old ( A ) C57BL/6 mice and ( B ) NZBxW/F1 mice were injected intraperitoneally with curli purified from Salmonella Typhimurium (STm) biofilms, or sterile PBS for controls, weekly for ( A ) 12 weeks or ( B ) 5 weeks. ( C-F ) Anti-C1q antibodies in serum (diluted 1:50) were detected using ELISA, normalized to aliquots of serum from an untreated aged MRL/lpr mouse as a positive control (1:50, top dotted line) and a negative control without serum (bottom dotted line). ( C ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from STm biofilms, 100 µg/kg LPS, 50 µg curli and 50 µg/kg LPS, or PBS for untreated controls, weekly for 3 weeks . ( D ) C57BL/6 mice were injected intraperitoneally with 100 µg curli purified from the biofilm of an E. coli isolate from the human microbiome (hEC), an E. coli isolate from the mouse microbiome (mEC), STm biofilms, or PBS for untreated controls, weekly for 4 weeks . ( E ) 129Sv mice were infected intragastrically with 10 7 CFU of wild-type (WT) STm strain IR715, the isogenic curli-deficient mutant csgBA , or LB broth for uninfected controls, in two replicate experiments, and Week 6 serum was assayed. ( F ) C57BL/6 mice were infected intragastrically with 10 7 CFU of STm spiB or invAspiB mutant, or LB broth for uninfected controls, and monitored for 10 weeks. Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: ( A-B ) Unpaired t-test, ( C-E ) One-way ANOVA, or ( E ) Mixed-effects analysis, with Tukey’s multiple comparisons, comparisons within the legend indicating overall column factor (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).

Article Snippet: Tissue was incubated in antibody cocktails including 1:30 goat anti-mouse IgG conjugated to AlexaFluor 405 (Invitrogen A31553), 1:25 rat anti-mouse C3 (11H9) conjugated to AlexaFluor 647 (Santa Cruz Biotechnology sc-58926), and 1:20 rat anti-mouse C1q (7H8) conjugated to FITC (Santa Cruz Biotechnology sc-58920) diluted in PBS-T with 1% bovine serum albumin for 2 hours at room temperature, covered with a small circle of parafilm and kept in the dark underneath a lid to prevent evaporation and bleaching.

Techniques: Multiplex Assay, Luminex, Fluorescence, Injection, Purification, Sterility, Enzyme-linked Immunosorbent Assay, Positive Control, Negative Control, Microbiome, Infection, Mutagenesis, Analysis

Serum was collected from ( A, D ) pre-onset, ( B, E ) early-disease, and ( C,F ) late-disease NZBxW/F1 mice 24 hours after each weekly injection of curli purified from Salmonella Typhimurium biofilms or PBS for untreated controls. ( A-C ) ELISA assays detected anti-dsDNA antibodies in serum diluted ( A, B ) 1:250 or ( C ) 1:500 ( A-B, N = 8; C, N = 15). Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). ( D-F ) ELISA assays detected anti-C1q antibodies in serum diluted 1:50, normalized to the O. D. of positive control MRL/lpr serum, indicated by the top dotted line, and negative controls without serum are indicated by the bottom dotted line ( D-E, pre-bleed and Week 4 not assayed due to insufficient serum volume for the assay). Statistics: ( A-B, D-E ) Two-way ANOVA, or ( C, F ) Mixed-effects model, with Tukey’s multiple comparisons, comparisons within legends indicating overall column factor, (*p < 0.05, **p < 0.01).

Journal: PLOS Pathogens

Article Title: Salmonella infection and biofilms drive anti-C1q and anti-dsDNA autoantibodies in systemic autoimmunity

doi: 10.1371/journal.ppat.1014666

Figure Lengend Snippet: Serum was collected from ( A, D ) pre-onset, ( B, E ) early-disease, and ( C,F ) late-disease NZBxW/F1 mice 24 hours after each weekly injection of curli purified from Salmonella Typhimurium biofilms or PBS for untreated controls. ( A-C ) ELISA assays detected anti-dsDNA antibodies in serum diluted ( A, B ) 1:250 or ( C ) 1:500 ( A-B, N = 8; C, N = 15). Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). ( D-F ) ELISA assays detected anti-C1q antibodies in serum diluted 1:50, normalized to the O. D. of positive control MRL/lpr serum, indicated by the top dotted line, and negative controls without serum are indicated by the bottom dotted line ( D-E, pre-bleed and Week 4 not assayed due to insufficient serum volume for the assay). Statistics: ( A-B, D-E ) Two-way ANOVA, or ( C, F ) Mixed-effects model, with Tukey’s multiple comparisons, comparisons within legends indicating overall column factor, (*p < 0.05, **p < 0.01).

Article Snippet: Tissue was incubated in antibody cocktails including 1:30 goat anti-mouse IgG conjugated to AlexaFluor 405 (Invitrogen A31553), 1:25 rat anti-mouse C3 (11H9) conjugated to AlexaFluor 647 (Santa Cruz Biotechnology sc-58926), and 1:20 rat anti-mouse C1q (7H8) conjugated to FITC (Santa Cruz Biotechnology sc-58920) diluted in PBS-T with 1% bovine serum albumin for 2 hours at room temperature, covered with a small circle of parafilm and kept in the dark underneath a lid to prevent evaporation and bleaching.

Techniques: Injection, Purification, Enzyme-linked Immunosorbent Assay, Positive Control

( A ) Experimental scheme: MRL/lpr mice at age 6 weeks underwent weekly intraperitoneal injections of curli, purified from Salmonella Typhimurium biofilms or PBS for untreated controls, and periodic serum samples, taken 24 hours after each injection, for 6 weeks. ( B-C ) ELISA assays detected anti-dsDNA antibodies in serum diluted ( B ) 1:250 or ( C ) 1:500. ( D ) ELISA assay detected anti-C1q antibodies in serum diluted 1:50, normalized to the O.D. of the positive control untreated MRL/lpr serum. Dotted lines indicate relative O.D. of MRL/lpr positive control serum (top line) or negative control with no serum added (bottom line). Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: Two-way ANOVA with Sidak’s multiple comparisons, comparisons within legends indicating overall column factor, (*p < 0.05, **p < 0.01).

Journal: PLOS Pathogens

Article Title: Salmonella infection and biofilms drive anti-C1q and anti-dsDNA autoantibodies in systemic autoimmunity

doi: 10.1371/journal.ppat.1014666

Figure Lengend Snippet: ( A ) Experimental scheme: MRL/lpr mice at age 6 weeks underwent weekly intraperitoneal injections of curli, purified from Salmonella Typhimurium biofilms or PBS for untreated controls, and periodic serum samples, taken 24 hours after each injection, for 6 weeks. ( B-C ) ELISA assays detected anti-dsDNA antibodies in serum diluted ( B ) 1:250 or ( C ) 1:500. ( D ) ELISA assay detected anti-C1q antibodies in serum diluted 1:50, normalized to the O.D. of the positive control untreated MRL/lpr serum. Dotted lines indicate relative O.D. of MRL/lpr positive control serum (top line) or negative control with no serum added (bottom line). Week -1 denotes baseline samples collected from each group one week before the first injection (Week 0). Statistics: Two-way ANOVA with Sidak’s multiple comparisons, comparisons within legends indicating overall column factor, (*p < 0.05, **p < 0.01).

Article Snippet: Tissue was incubated in antibody cocktails including 1:30 goat anti-mouse IgG conjugated to AlexaFluor 405 (Invitrogen A31553), 1:25 rat anti-mouse C3 (11H9) conjugated to AlexaFluor 647 (Santa Cruz Biotechnology sc-58926), and 1:20 rat anti-mouse C1q (7H8) conjugated to FITC (Santa Cruz Biotechnology sc-58920) diluted in PBS-T with 1% bovine serum albumin for 2 hours at room temperature, covered with a small circle of parafilm and kept in the dark underneath a lid to prevent evaporation and bleaching.

Techniques: Purification, Blood/Plasma/Serum Samples, Injection, Enzyme-linked Immunosorbent Assay, Positive Control, Negative Control

MRL/lpr mice were intraperitoneally injected weekly with ( A ) PBS or ( B ) curli purified from Salmonella Typhimurium for 6 weeks and euthanized at 13 weeks old. Frozen tissue sections were stained with goat anti-mouse IgG-AlexaFluor405 (blue), rat anti-mouse C3-AlexaFluor647 (red), and rat anti-mouse C1q-FITC (green). ( A-B ) Representative images of glomeruli by confocal microscopy (63X objective). Sections shown are from two individual mice per group, scale bars represent 20 µm. ( C-F ) Images were quantified in ImageJ for mean fluorescence intensity (MFI) inside glomeruli of ( C ) IgG, ( D ) C3, ( E ) C1q, and ( F ) area was measured, within at least 15 glomeruli per mouse and averaged. Statistics: ( C-F ) Unpaired t-test (**p < 0.01).

Journal: PLOS Pathogens

Article Title: Salmonella infection and biofilms drive anti-C1q and anti-dsDNA autoantibodies in systemic autoimmunity

doi: 10.1371/journal.ppat.1014666

Figure Lengend Snippet: MRL/lpr mice were intraperitoneally injected weekly with ( A ) PBS or ( B ) curli purified from Salmonella Typhimurium for 6 weeks and euthanized at 13 weeks old. Frozen tissue sections were stained with goat anti-mouse IgG-AlexaFluor405 (blue), rat anti-mouse C3-AlexaFluor647 (red), and rat anti-mouse C1q-FITC (green). ( A-B ) Representative images of glomeruli by confocal microscopy (63X objective). Sections shown are from two individual mice per group, scale bars represent 20 µm. ( C-F ) Images were quantified in ImageJ for mean fluorescence intensity (MFI) inside glomeruli of ( C ) IgG, ( D ) C3, ( E ) C1q, and ( F ) area was measured, within at least 15 glomeruli per mouse and averaged. Statistics: ( C-F ) Unpaired t-test (**p < 0.01).

Article Snippet: Tissue was incubated in antibody cocktails including 1:30 goat anti-mouse IgG conjugated to AlexaFluor 405 (Invitrogen A31553), 1:25 rat anti-mouse C3 (11H9) conjugated to AlexaFluor 647 (Santa Cruz Biotechnology sc-58926), and 1:20 rat anti-mouse C1q (7H8) conjugated to FITC (Santa Cruz Biotechnology sc-58920) diluted in PBS-T with 1% bovine serum albumin for 2 hours at room temperature, covered with a small circle of parafilm and kept in the dark underneath a lid to prevent evaporation and bleaching.

Techniques: Injection, Purification, Tissue, Staining, Confocal, Microscopy, Fluorescence